Abstract

Basics of Compounding with Dilutions and Concentrates

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2017 - Volume 21, Number 1

Page(s): 39-45

Download in electronic PDF format for $75

Abstract

Pharmacists use various sources for obtaining the active pharmaceutical ingredient for compounding medications. In many cases, it is the pure drug (United States Pharmacopeia, National Formulary, or similar grade); in some cases, it can be a commercial dosage form; and, in some cases, it may be a dilution or concentrate. If the drug is not present at full strength, then adjustments may be necessary to obtain the required quantity of drug. Also, in many cases, it is necessary to use a dilution or a concentrate of a drug due to safety and quality reasons. Presented within this article are new sources of active pharmaceutical ingredients that are now available to aid pharmacists in meeting future United States Pharmacopeia <800> standards. It is critical that the pharmacist be aware of the strength of the drug and any other excipients that may be available.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 508-510	Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 376-380	Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol Author(s): Snyder Scott, Listecki Robert E
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 545	Liothyronine Sodium (T3) 5-mcg/Hydrocortisone 5-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 547	Liothyronine Sodium (T3) 5-mcg/Selenium 100-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 548	Liothyronine Sodium (T3) 5-mcg Slow-Release Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 306-309	Thyroid Potency Calculations Author(s): Stack Bob
Jul/Aug 2005 Pg. 268-273	Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Author(s): Milner Martin
May/Jun 2008 Pg. 200-207	Dilution and Compounding of Ziconotide for Intrathecal Administration Author(s): Buchta Tony, Fakata Keri, Stuart William
May/Jun 2007 Pg. 247	Levothyroxine Sodium 40-micro-g/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 22-23	The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Author(s): Brunner Scott
Jul/Aug 2003 Pg. 297	Chlorpromazine HCl 30-mg/mL Oral Concentrate Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 320-323	Long-term Physicochemical Stability of Concentrated Solutions of Sodium Valproate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Baltzis Alexandre, Braibant Maximilien, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Nov/Dec 2013 Pg. 505	Levothyroxine Sodium 100-mcg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 414-419	Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Jan/Feb 2004 Pg. 46-48	Basics of Compounding for Disorders of the External Ear Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 206-209	Basics of Compounding for Cold Sores or Fever Blisters Author(s): Allen Loyd V Jr
Jan/Feb 2005 Pg. 61	Standard Operating Procedure: Compounding with Concentrated Acids Author(s): Allen Loyd V Jr